Instrument number PB 13 of 2009
Amendment special arrangements under subsection 100(1) of the National Health Act 1953
I, ADRIANA PLATONA, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsection 100(1) of the National Health Act 1953.
Dated 30 January 2009
ADRIANA PLATONA
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment Special Arrangements — Chemotherapy Pharmaceuticals Access Program
1 Commencement
This instrument commences on 1 March 2009.
2 Amendment of PB 121 of 2008
Schedule 1 amends PB 121 of 2008.
Schedule 1 Amendments
[1] Schedule 2, item dealing with Irinotecan in the form I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL
omit from the column headed “Brand”:
Irinotecan-GA
[2] Schedule 2, item dealing with Vinorelbine in the form Solution for
I.V. infusion 10 mg (as tartrate) in 1 mL
in the column headed “Brand” insert in alphabetical order:
Vinorelbine 10 Link
[3] Schedule 2, item dealing with Vinorelbine in the form Solution for
I.V. infusion 50 mg (as tartrate) in 5 mL
in the column headed “Brand” insert in alphabetical order:
Vinorelbine 50 Link